Answers are grounded in this paper and cite their sources.
A patient with adult-onset vitelliform dystrophy received intravitreal injections of bevacizumab in one eye. During 4 months of follow-up, spectral domain optical coherence tomography (SD-OCT) showed a progressive decrease of yellowish deposits and complete resolution of subretinal fluid at the last followup. Despite the good anatomic outcome, the patient reported a mild decrease in visual acuity and persistent metamorphopsia. The clinical course and the correlation between the fundus findings and the morphologic information from SD-OCT data are described.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: